Recombinant Mouse IQ domain-containing protein J (Iqcj)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline for customers.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
IqcjIQ domain-containing protein J
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-110
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mus musculus (Mouse)
Target Names
Iqcj
Target Protein Sequence
MRLEELKRLQ NPLEQVDDGK YLLENHQLAM DVENNIENYP LSLQPLESKV KIIQRAWREY LQRQDPLEKR SPSPPSVSSD KLSSSVSMNT FSDSSTPVSV SRPLAWTVLH
Uniprot No.

Q&A

What is the IQ domain in Iqcj and how does it function in calmodulin binding?

The IQ domain in Iqcj is a specific amino acid sequence approximately 25 amino acids in length that conforms to the consensus pattern [I,L,V]QxxxRGxxx[R,K]. It forms an amphiphilic seven-turn α-helix capable of binding calmodulin in a Ca2+-independent manner. The non-polar face of the helix switches sides after the fifth turn, providing an additional surface for ligand contact. Key residues important for interactions with calmodulin include a hydrophobic amino acid at position 1, a conserved glutamine at position 2, basic charges at positions 6 and 11, and a variable glycine at position 7 .

IQ domains in proteins like Iqcj can serve to anchor calmodulin within cells, similar to how repeated IQ motifs function in the non-conventional myosin family. This binding can occur in either a Ca2+-dependent or Ca2+-independent manner, depending on the specific amino acid composition of the IQ motif .

How does Iqcj structure compare to other IQ domain-containing proteins?

Iqcj shares structural similarities with other IQ motif-containing proteins but has distinct features. Similar to IQCJ-SCHIP1, Iqcj likely contains an N-terminal IQ domain that interacts with calmodulin. In IQCJ-SCHIP1, both N-terminal and C-terminal sequences are required for functional interactions with binding partners, as deletion of either region disrupts protein interactions .

What expression systems are optimal for producing functional recombinant mouse Iqcj?

For optimal production of functional recombinant mouse Iqcj, the choice of expression system is critical. Based on observations with other recombinant mouse proteins:

Yeast Expression Systems: Pichia pastoris expression systems are recommended for Iqcj as they allow for natural folding and post-translational modifications, resulting in enhanced bioactivity and structural integrity compared to bacterial systems like E. coli . This is particularly important for IQ domain functionality, which depends on proper folding to maintain the amphiphilic α-helix structure required for calmodulin binding.

Mammalian Expression Systems: For functional studies requiring proper folding and post-translational modifications, mammalian expression using HEK293T cells has been successfully employed for IQ domain-containing proteins. This approach is particularly useful when studying protein-protein interactions that might be affected by phosphorylation or other modifications .

The choice between these systems should be guided by the intended application:

  • For structural studies: Yeast systems offer a good balance of yield and proper folding

  • For interaction studies: Mammalian systems provide the most native-like modifications

What purification strategies yield the highest quality recombinant mouse Iqcj protein?

Based on successful approaches with other recombinant mouse proteins containing IQ domains:

Recommended Purification Protocol:

  • Ion-exchange chromatography as the primary purification step

  • For IQ domain-containing proteins, avoid including calcium in purification buffers when studying Ca2+-independent interactions

  • Consider carrier-free preparations for applications where carriers like BSA could interfere with binding studies

Quality indicators for purified Iqcj should include:

  • Purity >95% as visualized by SDS-PAGE analysis

  • Retention of calmodulin binding capability in functional assays

  • Proper folding confirmed by circular dichroism or other structural methods

How can researchers accurately measure and characterize Iqcj-calmodulin interactions?

Several complementary methods have proven effective for studying interactions between IQ domain-containing proteins and calmodulin:

Microscale Thermophoresis (MST) Assay: This technique has been successfully used to determine binding affinities between IQ motif-containing proteins and calmodulin. The binding affinity increases with increasing concentrations of recombinant calmodulin, and the interaction can be disrupted when the IQ motif is deleted. For example, with IQCH, another IQ domain-containing protein, MST confirmed that the IQ motif is required for calmodulin binding .

Co-Immunoprecipitation: For validating protein-protein interactions in cellular contexts, co-IP assays can verify binding between Iqcj and calmodulin under different calcium conditions. This approach should include appropriate controls such as IQ motif deletion mutants .

CaM-Sepharose Pulldown Assays: These assays have been used to demonstrate differential binding of IQ motif proteins under high and low calcium conditions. For example, PEP-19 and neurogranin bind calmodulin in low calcium conditions but associate weakly in high calcium. This approach can distinguish between calcium-dependent and calcium-independent interactions .

What experimental controls are essential when studying Iqcj interactions?

Based on established protocols for IQ domain protein research:

Essential Controls for Interaction Studies:

  • Deletion mutants: Create Iqcj constructs with the IQ motif deleted to confirm specificity of the interaction

  • Calcium conditions: Test interactions in both calcium-free (with EGTA) and calcium-saturated conditions to determine calcium dependency

  • Competition assays: Use synthetic peptides constituting just the IQ motif to compete with full-length Iqcj in calmodulin binding assays

  • Mutant analysis: Introduce point mutations in key residues of the IQ motif (e.g., the conserved glutamine at position 2) to confirm the importance of specific amino acids

  • Non-binding control proteins: Include structurally similar proteins without IQ domains as negative controls

How can CRISPR-Cas9 technology be effectively employed to study Iqcj function in mice?

CRISPR-Cas9 technology offers a powerful approach to study Iqcj function:

Design Strategy:

  • Target exons containing the IQ domain coding sequence to disrupt protein function

  • Design guide RNAs (sgRNAs) targeting specific exons of Iqcj using tools like CHOPCHOP or CRISPOR

  • For complete knockout, target early exons to create frameshift mutations

Implementation Protocol (based on IQCH knockout study methodology ):

  • Synthesize complementary DNA oligos for each sgRNA target

  • Anneal and ligate oligos to an appropriate vector (e.g., pUC57-sgRNA)

  • Transform into DH5α competent cells and screen positive clones

  • Linearize the recombinant plasmid and purify by phenol-chloroform extraction

  • Perform in vitro transcription of sgRNAs using MEGAshortscript Kit

  • Co-inject mouse zygotes with Cas9 mRNA (~50 ng/μl) and sgRNA (~30 ng/μl)

  • Transfer injected zygotes to pseudopregnant recipients

  • Verify successful editing by PCR and sequencing of genomic DNA from offspring

Validation Methods:

  • PCR genotyping to confirm targeted deletion

  • RT-PCR to verify absence of transcript

  • Western blotting to confirm lack of protein expression

  • Functional assays to assess phenotypic consequences

What phenotyping approaches best reveal Iqcj functional roles in mice?

Based on studies of related IQ domain-containing proteins:

Primary Phenotyping Approaches:

  • Neuronal function assessments: Given the enrichment of IQ domain proteins in neuronal tissues, evaluate:

    • Electrophysiological recordings of neuronal activity

    • Behavioral tests for cognitive and motor functions

    • Neuronal morphology and synapse formation

  • Reproductive system analysis: Following findings with IQCH :

    • Fertility testing (pregnancy rates, litter sizes)

    • Histological examination of reproductive tissues

    • Sperm motility and morphology assessment

    • Molecular analysis of gene expression changes in reproductive tissues

  • Signaling pathway investigations:

    • Phosphorylation status of key signaling proteins

    • Calcium imaging to assess calcium homeostasis

    • RNA-seq for transcriptome-wide effects

What experimental design principles should be applied when studying Iqcj knockout phenotypes?

For robust experimental design in Iqcj studies:

Key Design Principles :

  • A priori power analysis: Ensure adequate group sizes to obtain statistical significance. Include alpha, power, and effect size calculations in methods.

  • Minimum sample sizes: Use at least n=5 independent samples per group for statistical analysis. Smaller groups should not be subjected to statistical analysis unless scientifically justified.

  • Randomization: Implement formal randomization when allocating animals to experimental groups to avoid bias. Use systematic approaches such as computer-generated random numbers rather than haphazard selection.

  • Blinding: Employ blinding when conducting qualitative scoring to minimize bias, especially for subjective assessments of phenotypes.

  • Factorial designs: Consider factorial experimental designs when evaluating combinations of factors (e.g., genotype and treatment) to maximize information gained while reducing animal numbers.

Reporting Requirements:

  • Detail randomization methods used

  • Report blinding procedures

  • Include sample size calculations

  • Provide clear statistical methods with measures of error or variability

How should researchers interpret conflicting data about Iqcj function?

When faced with conflicting data regarding Iqcj function:

Systematic Approach to Data Inconsistencies:

  • Evaluate experimental conditions: Different calcium concentrations can dramatically alter IQ domain protein interactions and functions .

  • Consider cellular context: IQ domain proteins may have different functions depending on the cellular environment. For example, IQGAP1 regulates Erk1/2 phosphorylation in mouse embryonic fibroblasts but is dispensable for MAPK signaling in some cancer cell lines .

  • Analyze protein isoforms: Check whether different isoforms or splice variants of Iqcj might explain functional differences.

  • Examine binding partners: Different binding partners can modulate Iqcj function. For example, IQ domain interactions with different partners like calmodulin, βIV-spectrin, or ion channels may result in distinct functional outcomes .

  • Compare methodologies: Different experimental approaches (in vitro binding vs. cellular assays vs. in vivo studies) might yield divergent results due to biological complexity.

How does Iqcj contribute to neuronal function and ion channel regulation?

Based on findings with related IQ domain-containing proteins like IQCJ-SCHIP1:

Iqcj likely plays a significant role in neuronal function through various mechanisms:

Ion Channel Interaction: IQCJ-SCHIP1 interacts with both βIV-spectrin and Kv7.2/3 channels, suggesting a role in organizing ion channel complexes in neurons. Importantly, IQCJ-SCHIP1 can interact with Kv7.2 and Kv7.3 channels through their intracellular C-terminal domain. This interaction is reduced by mutations affecting the 1-5-10 consensus calmodulin-binding motif but not disrupted by mutations in the AnkG-binding domain or calmodulin-binding IQ motif .

Neuronal Architecture: In knockout mice lacking IQCJ-SCHIP1, nodes of Ranvier (NR) showed morphological abnormalities, including increased diameter and decreased length, while maintaining normal protein composition. This suggests a role in shape stabilization rather than protein localization .

The following table from a study on IQCJ-SCHIP1 knockout mice illustrates morphological changes in nodes of Ranvier:

NR diameter (nm)NR length (nm)Length/diameter ratio
14 months
WT2400 ± 321494 ± 100.662 ± 0.009
Δ102583 ± 39**1431 ± 13*0.596 ± 0.009***
2.5 months
WT2265 ± 271452 ± 110.669 ± 0.009
Δ102622 ± 38***1377 ± 11***0.559 ± 0.010***

*p < 0.05; **p < 0.01; ***p < 0.001

What is the current understanding of Iqcj's role in immune system regulation?

While specific information about Iqcj's role in immune regulation is limited, insights can be drawn from studies of related IQ domain-containing proteins:

Potential Immune Functions:

  • Cytokine Signaling: IQ domain-containing proteins like IQGAP1 regulate multiple signaling pathways in immune cells, including the production of inflammatory cytokines. Research has shown that IQGAP1 deficiency impairs the ability of natural killer (NK) cells to produce inflammatory cytokines like IFN-γ and GM-CSF in response to receptor stimulation .

  • Immune Cell Motility: The ability of IQ domain proteins to interact with calmodulin and regulate cytoskeletal proteins suggests potential roles in immune cell migration and polarization. IQGAP1 deficiency in mice is associated with altered NK cell distribution, impaired cell polarization, and reduced motility .

  • Adaptive Immune Response: Interleukin-4 (IL-4), a key cytokine in immune regulation, plays a pivotal role in the differentiation of naive helper T cells (Th0) into Th2 cells. It stimulates B-cell and T-cell proliferation and can be used as a potential research target in conjunction with studies of IQ domain proteins in immune regulation .

For researchers investigating Iqcj's potential role in immune function, experiments might include:

  • Examining Iqcj expression in different immune cell populations

  • Testing effects of Iqcj deficiency on cytokine production and signaling

  • Investigating potential interactions with immune receptors or signaling components

How can researchers distinguish between direct and indirect effects of Iqcj in signaling pathways?

Distinguishing between direct and indirect effects requires a multi-faceted approach:

Recommended Methodologies:

  • Domain deletion and mutation analysis: Create a series of Iqcj constructs with specific domains deleted or key residues mutated. For example, with IQCJ-SCHIP1, deletion of either the N-terminal or C-terminal regions disrupted interactions with binding partners .

  • In vitro reconstitution experiments: Use purified components to determine whether interactions require additional proteins or can occur directly between Iqcj and putative partners.

  • Proximity labeling techniques: Methods like BioID or APEX2 can identify proteins in close proximity to Iqcj in living cells, helping to distinguish direct interactors from proteins affected downstream.

  • Temporal analysis of signaling events: Use time-course experiments with inducible expression or rapid inhibition systems to determine the sequence of events following Iqcj activation or inhibition.

  • Crosslinking mass spectrometry: This approach can capture direct protein-protein interactions by covalently linking proteins in close proximity before analysis.

What are the challenges in crystallizing Iqcj-calmodulin complexes and how can they be addressed?

Based on structural studies of related IQ domain-calmodulin complexes:

Key Challenges:

  • Conformational flexibility: IQ domains and calmodulin complexes can adopt multiple conformations depending on calcium levels, making crystal packing difficult.

  • Protein stability: The relatively small size of the IQ domain and its tendency to form amphiphilic helices can lead to aggregation or poor solubility.

  • Complex stoichiometry: Determining the correct ratio of Iqcj to calmodulin for crystallization can be challenging, as IQ motifs can bind calmodulin in different conformations.

Recommended Solutions:

  • Construct optimization: Design multiple constructs with varying lengths around the IQ domain. For calmodulin-binding studies, focused constructs containing just the IQ motif may be more successful than full-length protein .

  • Calcium condition screening: Test both calcium-free and calcium-saturated conditions, as the binding mode of calmodulin to IQ motifs can differ dramatically based on calcium concentration .

  • Co-expression strategies: Express Iqcj and calmodulin together to improve complex formation and stability.

  • Surface entropy reduction: Introduce mutations that reduce surface entropy to promote crystal contacts.

  • Alternative structural approaches: If crystallization proves challenging, consider cryo-electron microscopy or nuclear magnetic resonance for structural characterization.

How might research on Iqcj contribute to understanding neurological disorders?

Given the role of IQ domain-containing proteins in neuronal function:

Potential Contributions to Neurological Research:

  • Ion channel regulation: IQCJ-SCHIP1 interacts with Kv7 channels, which are implicated in epilepsy and other neurological disorders. Understanding how Iqcj modulates ion channel function could provide insights into channelopathies .

  • Cytoskeletal organization: IQ domain proteins interact with the neuronal cytoskeleton to maintain proper cellular architecture. In IQCJ-SCHIP1 knockout mice, nodes of Ranvier displayed altered morphology, suggesting roles in maintaining appropriate neuronal structures .

  • Signaling pathway modulation: By interacting with calmodulin, Iqcj likely influences calcium-dependent signaling pathways crucial for neuronal development and function.

  • Synaptic plasticity: Other IQ domain proteins regulate calmodulin availability at synapses, affecting synaptic plasticity mechanisms underlying learning and memory.

Researchers investigating Iqcj in neurological contexts should consider:

  • Examining Iqcj expression patterns in various neuronal populations

  • Exploring electrophysiological consequences of Iqcj manipulation

  • Investigating potential genetic associations with neurological disorders

  • Developing conditional knockout models to study region-specific effects

What are the emerging technologies that will advance Iqcj research in the coming years?

Several cutting-edge technologies are poised to transform research on IQ domain-containing proteins like Iqcj:

Emerging Technologies:

  • CRISPR base editing and prime editing: These refined CRISPR technologies allow for precise point mutations without double-strand breaks, enabling nuanced investigation of specific amino acid residues within the IQ domain .

  • Single-cell multi-omics: Integrated analysis of transcriptomics, proteomics, and metabolomics at the single-cell level will reveal cell-type-specific functions of Iqcj in heterogeneous tissues like brain.

  • AlphaFold and other AI structure prediction tools: These computational approaches can predict protein structures and protein-protein interactions, guiding experimental designs for studying Iqcj interactions.

  • Optogenetic and chemogenetic tools: These technologies enable temporal control of Iqcj function in specific cell populations, allowing researchers to dissect immediate versus downstream effects.

  • Cryo-electron tomography: This technique can visualize protein complexes in their native cellular environment, potentially revealing how Iqcj organizes protein networks within cells.

  • Protein interaction visualization: Advanced fluorescence techniques like FRET-FLIM and split-fluorescent proteins provide ways to visualize Iqcj interactions in living cells with high spatiotemporal resolution.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.